Tag: cosmetic regulatory compliance
-
Cosmetic Adverse Events: US FDA Requirements, MoCRA Rules, and Compliance Obligations
Cosmetic safety does not end once a product reaches the market. Under United States law, cosmetic companies are legally responsible for monitoring, documenting, and reporting cosmetic adverse events. With the enactment of the Modernization of Cosmetics Regulation Act (MoCRA), adverse event reporting has become a mandatory and enforceable requirement under the authority of the US…
-
Cosmeceutical FDA Meaning: What the Term Really Means Under US Law
The word “cosmeceutical” is widely used in marketing, product development, and consumer communication. It is often intended to describe cosmetic products that appear to deliver therapeutic or medical-like benefits. However, from a regulatory standpoint, the term cosmeceutical has no legal meaning under US FDA law. Understanding how the US FDA views the term “cosmeceutical” is…
-
OTC Cosmetic Products: How US FDA Regulates Cosmetics With Drug Functions
Many personal care products in the US marketplace appear to be simple cosmetics, yet they also perform therapeutic functions. These products are commonly referred to as OTC cosmetic products, meaning they have both cosmetic and over-the-counter (OTC) drug characteristics. Under the authority of the US FDA, products that both beautify and treat or prevent certain…
-
Drug vs Cosmetic Intent: How US FDA Determines Product Classification
One of the most critical regulatory questions for any personal care product is whether it is legally considered a cosmetic, a drug, or a combination product. This determination is driven primarily by product intent, which is evaluated based on claims, labeling, marketing, and consumer perception. Under the authority of the US FDA, product intent defines…
-
Trade Secret Ingredients in Cosmetics: US FDA Rules, MoCRA Expectations, and Compliance Strategy
Cosmetic formulations often represent years of research, development, and significant financial investment. For this reason, many cosmetic companies seek to protect certain ingredients as trade secrets. At the same time, cosmetic products sold in the United States must comply with strict ingredient disclosure and safety requirements enforced by the US FDA. The Modernization of Cosmetics…
-
Cosmetic Product Claims: How US FDA Regulates What You Can and Cannot Say
Cosmetic product claims are one of the most common sources of regulatory violations in the United States. While cosmetic labels and marketing materials are powerful tools for attracting consumers, they are also closely regulated by the US FDA. Claims that overstep legal boundaries can cause a cosmetic to be misbranded, reclassified as a drug, or…
-
Warning Statements in Cosmetic Labeling: US FDA Requirements and Compliance Obligations
Warning statements are a critical component of cosmetic labeling in the United States. Their purpose is to alert consumers to potential hazards associated with product use and to provide instructions that reduce the risk of injury or misuse. Under the authority of the US FDA, and reinforced by the Modernization of Cosmetics Regulation Act (MoCRA),…
-
Adulterated Cosmetics: Understanding US FDA Enforcement and MoCRA Compliance
Under United States law, cosmetic products must be safe for consumers under their intended conditions of use. When a cosmetic fails to meet safety or manufacturing standards, it may be classified as adulterated. An adulterated cosmetic is illegal to distribute in the United States and may trigger enforcement action by the US FDA. With the…
-
Misbranded Cosmetics: How US FDA Defines, Detects, and Enforces Violations
Under United States law, cosmetic products must be labeled and marketed in a truthful, accurate, and non-misleading manner. When a cosmetic fails to meet these legal standards, it is considered misbranded. A misbranded cosmetic is illegal to distribute in the United States and may trigger enforcement action by the US FDA. With the implementation of…